OverviewSuggest Edit

Human Longevity Inc. (HLI) is a genomics and cell therapy-based diagnostic and therapeutic company. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building a comprehensive database on human genotypes and phenotypes to tackle the diseases associated with aging-related human biological decline. HLI is also leading the development of cell-based therapeutics to address age-related decline in endogenous stem cell function. HLI is concentrating on cancer, diabetes and obesity, heart and liver diseases, and dementia.
TypePrivate
Founded2013
HQSan Diego, CA, US
Websitehumanlongevity.com
Employee Ratings2.4
Overall CultureC+

Latest Updates

Employees (est.) (Sept 2021)74
Job Openings15
Cybersecurity ratingCMore

Key People/Management at Human Longevity

David Karow

David Karow

President and Chief Innovation Officer
Wei-Wu He

Wei-Wu He

Executive Chairman
Travis Lacey

Travis Lacey

Chief Corporate Development Officer
Anita Cosgrove

Anita Cosgrove

Senior Vice-President, Strategic Business Development
Scott Treml

Scott Treml

Vice President, Operations and Strategic Partnerships
Jacqueline Steele

Jacqueline Steele

Vice President, Clinical Operations
Show more

Human Longevity Office Locations

Human Longevity has offices in San Diego, Mountain View and Singapore
San Diego, CA, US (HQ)
4570 Executive Dr
Mountain View, CA, US
800 W El Camino Real #180
Show all (3)

Human Longevity Financials and Metrics

Summary Metrics

Founding Date

2013

Human Longevity total Funding

$580.5 m

Human Longevity latest funding size

$500 m

Time since last funding

5 years ago

Human Longevity investors

Human Longevity's latest funding round in April 2016 was reported to be $500 m. In total, Human Longevity has raised $580.5 m. Human Longevity's latest valuation is reported to be $1.2 b.
View all funding rounds

Human Longevity Revenue

Market valuation

1.2b
Show all financial metrics

Human Longevity Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

Human Longevity Online and Social Media Presence

Embed Graph

Human Longevity Company Culture

  • Overall Culture

    C+

    68/100

  • CEO Rating

    D-

    57/100

  • Compensation

    B

    76/100

  • Diversity

    C+

    68/100

Learn more on Comparably

Human Longevity News and Updates

SCOR Global Life partners with Human Longevity, Inc. to bring data-driven health intelligence to life insurance policyholders

SAN DIEGO, Aug. 29, 2018 /PRNewswire/ -- SCOR Global Life continues to promote health and wellness initiatives through a new partnership with Human Longevity, Inc. (HLI), an innovator in providing data-driven health intelligence to a broader range of consumers. HLI delivers individual...

Human Longevity chief says genome sequencing can help people cheat death

J. Craig Venter’s company tests healthy consumers, something that’s not been done before, he says.

Human Longevity Blogs

Human Longevity’s Largest Study of its Kind Shows Early Detection of Disease and Disease Risks in Adults

Study participants were evaluated with Human Longevity’s multi-modal precision health platform, the Health Nucleus™ The assessment yielded highly actionable findings, most of which were not previously known, resulting in early identification of disease and disease risk in conditions that can lead to…

World Expert in Genetics Joins Human Longevity as Chief Medical Officer

(SAN DIEGO) November 13, 2019 – C. Thomas Caskey, MD, FACP, FACMG, FRSC and Professor, Molecular & Human Genetics at the Baylor College of Medicine, leads HLI’s team to expand genetic assessments to worldwide client base Dr. Wei Wu He, Executive Chairman of Human Longevity, Inc., said, “Our clie…

HUMAN LONGEVITY CLOSES $30 MILLION FINANCING FROM EMERGING TECHNOLOGY PARTNERS AND OTHER LEADING HEALTHCARE INVESTORS TO RENEW ITS COMMITMENT TO LONGEVITY AND PRECISION HEALTH

SAN DIEGO, CA., November 6, 2019 — Human Longevity, Inc. (“HLI”), an innovator in providing data-driven precision health intelligence platform for physicians and patients, today announced a $30 million financing from veteran biotech investment firms and investors. Existing investor Emerging Technolo…

Researchers look beyond BMI to predict obesity-related disease risk

(SAN DIEGO) – October 11, 2018 – Scientists at Scripps Research and collaborating corporate and academic partners have found a new way to use distinct molecular “signatures” from people with obesity to predict risk of developing diabetes and cardiovascular disease, an advance that could broaden the …

Human Longevity Appoints Dr. David Karow, M.D., Ph.D., as Interim Chief Executive Officer, Invigorating Company’s Vision to Drive Health Intelligence

Leadership Team Refined and Strengthened (SAN DIEGO) – July 13, 2018 – Human Longevity, Inc. (HLI), the genomics-powered, health intelligence company, announced today that David Karow M.D., Ph.D., has been appointed Interim Chief Executive Officer by the company’s Board of Directors. Serving most re…

Heart Disease and American Men

Half of all men who die suddenly of coronary heart disease have no previous symptoms.
Show more

Human Longevity Frequently Asked Questions

  • When was Human Longevity founded?

    Human Longevity was founded in 2013.

  • Who are Human Longevity key executives?

    Human Longevity's key executives are David Karow, Wei-Wu He and Travis Lacey.

  • How many employees does Human Longevity have?

    Human Longevity has 74 employees.

  • Who are Human Longevity competitors?

    Competitors of Human Longevity include BenevolentAI, Vazyme Biotech and 54gene.

  • Where is Human Longevity headquarters?

    Human Longevity headquarters is located at 4570 Executive Dr, San Diego.

  • Where are Human Longevity offices?

    Human Longevity has offices in San Diego, Mountain View and Singapore.

  • How many offices does Human Longevity have?

    Human Longevity has 3 offices.